| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 60.638 | 133.794 | 30.494 | 1.722 | - | 0 | 0 | 0 | - | - |
| Total Income - EUR | 75.336 | 135.418 | 36.013 | 1.723 | - | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 72.917 | 134.068 | 42.451 | 10.501 | - | 0 | 0 | 0 | - | - |
| Gross Profit/Loss - EUR | 2.418 | 1.350 | -6.438 | -8.778 | - | 0 | 0 | 0 | - | - |
| Net Profit/Loss - EUR | 158 | 412 | -6.798 | -8.795 | - | 0 | 0 | 0 | - | - |
| Employees | 2 | 2 | 2 | 1 | - | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Terapy-K Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.724 | 5.031 | 4.013 | 403 | - | 388 | 379 | 381 | - | - |
| Current Assets | 13.422 | 13.498 | 2.897 | 76 | - | 73 | 71 | 72 | - | - |
| Inventories | 12.405 | 12.727 | 2.758 | 0 | - | 0 | 0 | 0 | - | - |
| Receivables | 45 | 53 | 44 | 43 | - | 41 | 40 | 41 | - | - |
| Cash | 972 | 717 | 95 | 33 | - | 32 | 31 | 31 | - | - |
| Shareholders Funds | -1.289 | -864 | -8.383 | -17.072 | - | -16.424 | -16.059 | -16.109 | - | - |
| Social Capital | 225 | 223 | 219 | 215 | - | 207 | 202 | 203 | - | - |
| Debts | 20.435 | 29.937 | 29.487 | 31.485 | - | 30.290 | 29.618 | 29.710 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Terapy-K Srl